OPPM
WVE icon

Opus Point Partners Management’s Wave Life Sciences WVE Stock Holding History

Opus Point Partners Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-9,716
Closed -$377K – 73
2019
Q1 		$377K Buy
+9,716
New +$394K 0.51% 49

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Opus Point Partners Management's WVE Position: Q2 2019 in Review

Opus Point Partners Management sold out of Wave Life Sciences (WVE) in Q2 2019, closing a stake of 9,716 shares — an estimated $377K sold.

Opus Point Partners Management first reported a position in WVE in Q1 2019 and held it in 1 quarter. The position peaked at $377K in Q1 2019. 100 funds tracked by Wall St. Rank hold WVE as of Q2 2019.

  • Opus Point Partners Management reported no remaining Wave Life Sciences position as of Q2 2019 after selling out during the quarter.
  • Opus Point Partners Management sold 9,716 Wave Life Sciences shares in Q2 2019, an estimated $377K.
  • Opus Point Partners Management first reported a position in Wave Life Sciences in Q1 2019 and held it in 1 quarter.
  • Opus Point Partners Management's Wave Life Sciences position peaked at $377K in Q1 2019.
  • 100 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2019.

Based on Opus Point Partners Management's 13F filing for Q2 2019, filed 14 Aug 2019.